Business
AstraZeneca and Johnson & Johnson given green light to resume US coronavirus vaccine trials – ABC News
In a sign of progress in the race to develop a vaccine for COVID-19, AstraZeneca’s resumption of its US clinical trial is set to be soon followed by Johnson & Johnson…
AstraZeneca has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week.
Key points:
- Both vaccine candidates had been forced to pause US trials after participant illnesses
- But both have been cleared to resume after it was found the vaccines were not the cause
- The race for a vaccine comes as coronavirus infections rise in dozens of countries
The news signalled progress against the novel coronavirus…
-
General20 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General9 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News16 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News9 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership